Rinoserebral Mukormikozlu Olgunun Yönetimi
Özet
Rinoserebral mukormikoz tanısı konulan 48 yaşındaki kadın hasta, rinoplasti ameliyatı sonrası gelişen diyabetik ketoasidoz (DKA) ve kardiyak arrest tablosuyla acil servise başvurmuş, resüsitasyon sonrası yoğun bakım ünitesine kabul edilmiştir. Özgeçmişinde 20 yıldır Tip 2 Diabetes Mellitus öyküsü bulunan hastada, DKA ve septik şok ön tanılarıyla geniş spektrumlu antibiyotik, sıvı ve insülin tedavileri başlanmış, sürekli renal replasman tedavisi ve kardiyak destek uygulanmıştır. Takiplerinin 11. gününde nazal bölgede mukormikoz ile uyumlu nekrotik dokuların tespiti üzerine histopatolojik doğrulama yapılmış, intravenöz lipozomal amfoterisin B tedavisi eklenerek cerrahi debridman gerçekleştirilmiştir. Cerrahi müdahale ve uygulanan tüm antifungal, antibakteriyel ve destek tedavilerine rağmen klinik durumu kötüleşen hasta, takibinin 41. gününde Acinetobacter baumannii kaynaklı septik şok nedeniyle hayatını kaybetmiştir. İnvaziv mantar enfeksiyonu olan mukormikoz, özellikle ketoasidozlu diyabet hastalarında yüksek mortaliteye sahiptir ve erken tanı, agresif cerrahi debridman ile antifungal tedavinin önemini ortaya koymaktadır.
Referanslar
Kauffman CA, Malani AN. Zygomycosis: an emerging fungal infection with new options for management. Curr Infect Dis Rep 2007; 9:435-40.
Farmakiotis D, Kontoyoyiannis DP. Mucormycoses. Infect Dis Clin North Am 2016: 30:143-63.
Lanternier F, Sun HY, Ribaoud P, et al. Mucormycosis in organ and stem cell transplant recipients. Clin Infect Dis 2012: 54:1629.
Almyroudis NG, Sutton DA, Linden P, et al. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literatüre. Am J Transplant 2006; 6:2365-74.
Lelievre L, Garcia-Hermoso D, Abdoul H, et al. Posttraumatic mucormycosis: a nationwidw study in France and review of the literatüre. Medicine (Baltimore) 2014: 93:395-404.
Legrand M, Gits-Muselli M, Boutin L, et al. Detection of Circulating Mucorales DNA in Critically Ill Burn Patients: Preliminary Report of a Screening Strategy for Early Diognosis and Treatment. Clin Infect Dis 2016:63:1312-17.
Prakash H, Chakrabarti A. Global Epidemiology of Mucormycosis. J Fungi (Basel). 2019 Mar 21;5(1):26. doi: 10.3390/jof5010026.
Rammaert B, Lanternier F, Zahar JR, et al. Healthcare-associated mucormycosis. Clin. Infect. Dis. 2012, 54 (Suppl. 1), S44–S54.
Rajagopalan S. Serious infections in elderly patients with diabetes mellitus. Clin Infect Dis 2005;40:990-6.
Shields JA, Shields CL. Eyelid, Conjunctival, and Orbital Tumors: An Atlas and Textbook, 3rd ed, L,ppincott Williams&Wilkins, Pheladelphia 2016.
Machourt M, Larche J, Burton K, et al. Genetic identification of the main oportunistic Mucorales by PCR-restriction fragment length polymorphism. J Clin Microbiol 2006; 44:805-10.
Hammond SP, Bialek R, Milner Da, et al. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol 2011; 49:2151-3.
Walsh TJ, Gamaletsou MN, McGinnis MR, et al. Early clincal and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis 2012; 54 Suppl 1:S55-60.
Schrödl W, Heydel T, Schwartze VU, et al. Direct analysis and identification of pathogenic Lichtheimia species by matrix-asisted laser desorption ionization-time of flight analyzer- mediated mass spectrometry. J Clin Microbiol 2012; 50:419-27.
Cassagne C, Ranque S, Normand AC, et al. Mould routine identification in the clinical laboratory by matrix-asisted laser desorption ionization-time of -flight mass spectrometry. PLoS One 2011; 6:e28425. doi: 10.1371/journal.pone.0028425.
Ling H, Yuan Z, Shen J, et al. Accuracy of matrix-asisted laser desorption ionization-time of flight mass spectrometry for identification of clinical pathogenic fungi: a meta-analysis. J Clin Microbiol 2014; 52:2573-82.
Spellberg B, Walsh TJ, Kontoyiannis DP, et al. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009; 48:1743-51.
Farmakiotis D, Kontoyiannis DP. Mucormycoses. Infect Dis Clin North Am 2016; 30:143-63.
Zilberberg MD, Shorr AF, Huang H, et al. Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data. BMC Infect Dis. 2014 Jun 5;14:310. doi: 10.1186/1471-2334-14-310.
Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005 Sep 1;41(5):634-53.
Karslıoğlu French E, Donihi AC, et al. Diabetic ketoacidosis and hyperosmolar hyperglicemic syndrome: review of acute decompensated diabetes in adult patients. BMJ 2019;365:l1114. doi: 10.1136/bmj.l1114.
Lebovitz HE, Banerji MA. Ketosis-Prone Diabetes (Flatbush Diabetes): an Emerging Worldwide Clinically Important Entity. Curr Diab Rep. 2018;18(11):120. doi:10.1007/s11892-018-1075-4
Gagakhedkar GR. Diabetic Ketoacidosis and Intensive Care. Journal of Research & Innovation in Anesthesia 2019; 4(2):29-31.
Brutsaert E, (2019). Diabetic Ketoacidosis (DKA)- Endocrine and Metabolic Disorders – MSD Manual Professional Edition. Retrieved 20 November 2019, from https:/www.msdmanuals.com/en-in/Professional/endocrine-and-metabolic-disorders/diabetes-mellitus-and-disorders-of-carbonhydrate-metabolism/diabetic-ketoacidosis-dka.
Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglisemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 2009;32(7):1335-1343.
Ramanesh A. Incidence and long term outcomes of adult patients with diabetic ketoacidosis admitted to intensive care: a retrospective cohort study. J Intensive Care Soc 2016;17(3):222-233.